The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Individual-patient monitoring in clinical practice: are available health status surveys adequate?
McHorney, C. A., & Tarlov, A. R. (1995) · Quality of Life Research · doi:10.1007/bf01593882 · Cited by 2,206
Riboli, E., Hunt, K., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondière, U., Hémon, B., Casagrande, C., Vignat, J., et al. (2002) · Public Health Nutrition · doi:10.1079/phn2002394 · Cited by 1,866
Young, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913
Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D. (1996) · Diabetologia · doi:10.1007/s001250050586 · Cited by 695
Ziegler, D., Hanefeld, M., Ruhnau, K. J., Mei\ner, H. P., Lobisch, M., Sch�tte, K., Gries, F. A., & The ALADIN Study Group (1995) · Diabetologia · doi:10.1007/bf00400603 · Cited by 525
Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy
Bril, V., & Perkins, B. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2048 · Cited by 472
Self-citation
Research works printed but not linked: 45
- Maser, 1989, Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study, Diabetes, 38, 1456, 10.2337/diabetes.38.11.1456 · DOI
- Fedele, 1997, A multicenter study on the prevalence of diabetic neuropathy in Italy, Diabetes Care, 20, 836, 10.2337/diacare.20.5.836 · DOI
- Apfel, 2001, Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials, J Neurol Sci, 189, 3, 10.1016/S0022-510X(01)00584-6 · DOI
- Harris, 1993, Symptoms of sensory neuropathy in adults with NIDDM in the US population, Diabetes Care, 16, 1446, 10.2337/diacare.16.11.1446 · DOI · Paper page
- Boulton, 1985, The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population, Diabetes Care, 8, 125, 10.2337/diacare.8.2.125 · DOI
- Marchettini, 2004, Pain in diabetic neuropathy case study: Whole patient management, Eur J Neurol, 11, 12, 10.1111/j.1471-0552.2004.00795.x · DOI
- O'Hare, 1994, Prevalence and forms of neuropathic morbidity in 800 diabetics, Jr J Med Sci, 163, 132, 10.1007/BF02965972 · DOI
- Hong, 1998, Neuropathy in non-insulin-dependent diabetes mellitus. The significance of symptoms, Scand J Prim Health Care, 16, 233
- Valk, 1994, Complaints of neuropathy related to the clinical and neurophysiological assessment of nerve function in patients with diabetes mellitus, Diabetes Res Clin Pract, 26, 29, 10.1016/0168-8227(94)90136-8 · DOI
- 2005, Standards of medical care in diabetes (Position Statement), Diabetes Care, 28, S4
- Bastyr, 2002, Neuropathy Total Symptom Score-6 Questionnaire (NTSS-6) is a valid instrument for assessing the positive symptoms of diabetic peripheral neuropathy (DPN), Diabetes, 51, A199
- Scott, 1976, Graphic representation of pain, Pain, 2, 175, 10.1016/0304-3959(76)90113-5 · DOI · Paper page
- Dyck, 2002, Electronic case-report forms of symptoms and impairments of peripheral neuropathy, Can J Neurol Sci, 29, 258, 10.1017/S0317167100002043 · DOI
- Backonja, 1998, Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial, JAMA, 280, 1831, 10.1001/jama.280.21.1831 · DOI · Paper page
- Rowbotham, 2004, Venlafaxine extended release in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study, Pain, 110, 697, 10.1016/j.pain.2004.05.010 · DOI · Paper page
- Goldstein, 2005, Duloxetine vs placebo in patients with painful diabetic neuropathy, Pain, 116, 109, 10.1016/j.pain.2005.03.029 · DOI · Paper page
- Melzack, 1975, The McGill Pain Questionnaire: Major properties and scoring methods, Pain, 1, 277, 10.1016/0304-3959(75)90044-5 · DOI · Paper page
- Galer, 2002, The lidocaine patch 5% effectively treats all neuropathic pain qualities: Results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale, Clin J Pain, 18, 297, 10.1097/00002508-200209000-00004 · DOI · Paper page
- Keller, 2004, Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain, Clin J Pain, 20, 309, 10.1097/00002508-200409000-00005 · DOI · Paper page
- Feldman, 1994, A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy, Diabetes Care, 17, 1281, 10.2337/diacare.17.11.1281 · DOI · Paper page
- Cornblath, 1999, Total neuropathy score: Validation and reliability study, Neurology, 53, 1660, 10.1212/WNL.53.8.1660 · DOI · Paper page
- Patrick, 1999, Quality of life of women with urinary incontinence: Further development of the incontinence quality of life instrument (I-QOL), Urology, 53, 71, 10.1016/S0090-4295(98)00454-3 · DOI · Paper page
- Lohr, 1996, Evaluating quality-of-life and health status instruments: Development of scientific review criteria, Clin Ther, 18, 979, 10.1016/S0149-2918(96)80054-3 · DOI · Paper page
- Vickrey, 2000, Development of a health-related quality of life measure for peripheral neuropathy, Neurorehabil Neural Repair, 14, 93, 10.1177/154596830001400202 · DOI
- Ziegler, 1999, Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month multicenter randomized controlled trial (ALADIN III Study). Alpha-Lipoic Acid in Diabetic Neuropathy, Diabetes Care, 22, 1296, 10.2337/diacare.22.8.1296 · DOI · Paper page
- Masson, 1989, A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy, Pain, 38, 25, 10.1016/0304-3959(89)90068-7 · DOI
- Galer, 2000, Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life, Diabetes Res Clin Pract, 47, 123, 10.1016/S0168-8227(99)00112-6 · DOI · Paper page
- Vrethem, 2002, Painful polyneuropathy in patients with and without diabetes: Clinical, neurophysiologic, and quantitative sensory characteristics, Clin J Pain, 18, 122, 10.1097/00002508-200203000-00008 · DOI
- Benbow, 1999, Painful diabetic neuropathy, Diabet Med, 16, 632, 10.1046/j.1464-5491.1999.00028.x · DOI
- Perrin, 2004, The reliability and validity of a self-administered version of the neuropathy total symptom score-6-SA (NTSS-6-SA), Diabetologia, 47, A35
- Brown, 2004, The prevalence and characteristics of type 2 diabetes mellitus patients with positive sensory symptoms of diabetic peripheral neuropathy, Diabetes, 53, A508
- Dyck, 2000, Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: A study of three cohorts, Diabetes Care, 23, 510, 10.2337/diacare.23.4.510 · DOI · Paper page
- 1997, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, 20, 1183, 10.2337/diacare.20.7.1183 · DOI · Paper page
- Dyck, 1988, Detection, characterization, and staging of polyneuropathy: Assessed in diabetics, Muscle Nerve, 11, 21, 10.1002/mus.880110106 · DOI · Paper page
- Dyck, 1995, Variables influencing neuropathic endpoints: The Rochester Diabetic Neuropathy Study of Healthy Subjects, Neurology, 45, 1115, 10.1212/WNL.45.6.1115 · DOI · Paper page
- Vinik, 2002, LY333531 treatment improve diabetic peripheral neuropathy (DPN) with symptoms, Diabetes, 51, A79
- Kulseng-Hanssen, 2003, The development of a questionnaire to measure the severity of symptoms and the quality of life before and after surgery for stress incontinence, BJOG, 110, 983, 10.1111/j.1471-0528.2003.01406.x · DOI
- Dyck, 1997, Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort, Neurology, 49, 229, 10.1212/WNL.49.1.229 · DOI · Paper page
- Nelsen, 1999, Quality-of-life questionnaire for patients taking antihypertensive medication, Clin Ther, 21, 1771, 10.1016/S0149-2918(99)80055-1 · doi:10.1016/s0149-2918(99)80055-1
- Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310 · DOI · Paper page
- Ametov, 2003, The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: The SYDNEY trial, Diabetes Care, 26, 770, 10.2337/diacare.26.3.770 · DOI · Paper page
- Vinik, 2005, Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial, Clin Ther, 27, 1164, 10.1016/j.clinthera.2005.08.001 · DOI · Paper page
- Hotta, 2001, Clinical efficacy of Fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: A 52-week multi-center placebo-controlled double-blind parallel group study, Diabetes Care, 24, 1776, 10.2337/diacare.24.10.1776 · DOI · Paper page
- Dyck, 1986, Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis, Neurology, 36, 1300, 10.1212/WNL.36.10.1300 · DOI
- 1985, Rating scales and assessment instruments for use in pediatric psychopharmacology research, Psychopharmacol Bull, 21, 714
Cited by
NeuPSIG guidelines on neuropathic pain assessment
Haanpää, M., Attal, N., Backonja, M., Baron, R., Bennett, M., Bouhassira, D., Cruccu, G., Hansson, P., Haythornthwaite, J. A., Iannetti, G. D., et al. (2011) · Pain · doi:10.1016/j.pain.2010.07.031 · Cited by 1,060
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
Challenges of neuropathic pain: focus on diabetic neuropathy
Rosenberger, D. C., Blechschmidt, V., Timmerman, H., Wolff, A., & Treede, R.-D. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02145-7 · Cited by 325
Diabetic Painful and Insensate Neuropathy: Pathogenesis and Potential Treatments
Obrosova, I. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.07.004 · Cited by 272
The Leptin-Deficient (ob/ob) Mouse
Drel, V. R., Mashtalir, N., Ilnytska, O., Shin, J., Li, F., Lyzogubov, V. V., & Obrosova, I. G. (2006) · Diabetes · doi:10.2337/db06-0885 · Cited by 264
Metadata
- Authors
- Bastyr, E. J., Price, K. L., & Bril, V.
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 27
- Issue
- 8
- Pages
- 1278-1294
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W2085309918
- Cited by
- 202
- References
- 8
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. https://app.cochat.ai/papers/10.1016/j.clinthera.2005.08.002
- The paper
- Bastyr, E. J., Price, K. L., & Bril, V. (2005). Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2005.08.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.